Fattori epigenetici ed evoluzione della curva nei pazienti affetti da scoliosi idiopatica dell’adolescente: studio pilota

Title

Code

EpigenAIS

Type

Sperimentale

Start Year

2022

Status

Terminato

Principal Investigator

051-6366926

alberto.ruffilli@ior.it

Ruffilli Alberto, MD

1st Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica I

Director

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. EpigenAIS

Monday 4 July 2022, 13:53

PG0010399_2022_EpigenAIS.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Fattori epigenetici ed evoluzione della curva nei pazienti affetti da scoliosi idiopatica dell’adolescente: studio pilota

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Fattori epigenetici ed evoluzione della curva nei pazienti affetti da scoliosi idiopatica dell’adolescente: studio pilota

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in